Oxidative stress induced by fluoroquinolones on treatment for complicated urinary tract infections in Indian patients [0.03%]
氟喹诺酮类药物治疗印度患者复杂性尿路感染的氧化应激反应
V Talla,Pr Veerareddy
V Talla
The aim of the study is to examine the oxidative stress in patients on fluoroquinolones (ciprofloxacin, levofloxacin, gatifloxacin) therapy for complicated urinary tract infections and to correlate with plasma concentrations at different ti...
Cardioprotective Effects of Lagenaria siceraria Fruit Juice on Isoproterenol-induced Myocardial Infarction in Wistar Rats: A Biochemical and Histoarchitecture Study [0.03%]
Hubbard南瓜果 juice对异丙肾上腺素致Wistar大鼠心肌梗死保护作用的生化及组织学研究
A Upaganlawar,R Balaraman
A Upaganlawar
The present study was designed to evaluate the cardioprotective effects of Lagenaria siceraria fruit juice in isoproterenol-induced myocardial infarction. Rats injected with isoproterenol (200 mg/kg, s.c.) showed a significant increase in t...
Litsea deccanensis ameliorates myocardial infarction in wistar rats: evidence from biochemical and histological studies [0.03%]
化学生物学和组织学研究证据表明山姜属德干落叶树改善大鼠心肌梗死
Bharath P Kumar,Mari M Kannan,Darlin S Quine
Bharath P Kumar
The present study was designed to evaluate the cardioprotective effects of methanolic extract of Litsea deccanensis (MELD) against isoproterenol-induced myocardial infarction in rats by studying cardiac markers, lipid peroxidation, lipid pr...
Antimicrobial activity of the extract of stem bark of diplotropis ferruginea benth [0.03%]
杜氏木本科属植物铁锈多扭藤茎皮提取物的抗菌活性
Gs Cerqueira,Nfm Rocha,Jrgs Almeida et al.
Gs Cerqueira et al.
This is the first report about the antibacterial activity of Diplotropis ferruginea Benth. In this study, the ethanol extract of D. ferruginea was tested for its antimicrobial activity against strains gram-positive and gram-negative. In ord...
Formulation and optimization of mucoadhesive nanodrug delivery system of acyclovir [0.03%]
阿昔洛韦粘膜给药纳米制剂的优化研究
Uv Bhosale,Devi V Kusum,N Jain
Uv Bhosale
Acyclovir is an antiviral drug used for the treatment of herpes simplex virus infections, with an oral bioavailability of only 10-20% [limiting absorption in gastrointestinal tract to duodenum and jejunum] and half-life of about 3 h, and is...
Preparation and characterization of pioglitazone cyclodextrin inclusion complexes [0.03%]
吡格列酮环糊精包合物的制备及其表征研究
V Pandit,R Gorantla,K Devi et al.
V Pandit et al.
Pioglitazone, a class II Biopharmaceutical Classification System drug having poor water solubility and slow dissolution rate may have a negative impact on its subtherapeutic plasma drug levels leading to therapeutic failure. In order to imp...
Formulation and evaluation of cephalexin extended release matrix tablets using 3 factorial design [0.03%]
应用三因素方差法设计制定和评价头孢拉定缓释矩阵片剂配方
V Jishnu,R Prabhakaran,Rm Gilhotra
V Jishnu
The aim of the present investigation was to prepare extended release film coated matrix tablets of cephalexin using binary mixture of two grades of hydrophilic polymer, hydroxypropyl methyl cellulose (HPMC), by direct compression method. Re...
P Wal,A Wal,S Gupta et al.
P Wal et al.
Herbal formulations being widely accepted therapeutic agents as antidiabetics, antiarthritics, hepatoprotectives, cough remedies, memory enhancers, and adaptogens. The commonest myth regarding herbal medicines is that these medicines are co...
Patient-physician Communication Barrier: A Pilot Study Evaluating Patient Experiences [0.03%]
医患沟通障碍：评估患者体验的试点研究
Tm Khan,Ma Hassali,Msm Al-Haddad
Tm Khan
This study aims to identify the patient-physician communication barriers in the primary healthcare setting in Pulau Penang, Malaysia. A cross-sectional study was designed to attain the objectives of the study. A self-developed 17-item study...
In-silico Comparative Study and Quantitative Structure-activity Relationship Analysis of Some Structural and Physiochemical Descriptors of Elvitegravir Analogs [0.03%]
依维替拉格类似物的一些结构和物理化学描述符的体内比较研究及定量构效关系分析
R Satpathy,S Ghosh
R Satpathy
Elvitegravir is a new-generation drug which acts as an integrase inhibitor of the HIV virus. The potential inhibition has been tested from the clinical trial data. Here the work basically deals with the quantitative structure-activity relat...